Company Profile
Adaptive Biotechnologies Stock Price, News & Analysis
Company overview
Business overview
Adaptive Biotechnologies is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Adaptive Biotechnologies is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Adaptive Biotechnologies follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Adaptive Biotechnologies sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
ADPT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Adaptive still has a clean platform story in immune-system diagnostics and therapeutics, but the commercial side is where the company has to keep proving itself. The update is less about one binary event and more about whether the core immune products continue to move from scientific capability into routine clinical use.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
Source: Adaptive Biotechnologies
- 03
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
Source: Adaptive Biotechnologies
- 04
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: Adaptive Biotechnologies
- 05
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
Source: Adaptive Biotechnologies
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.